Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.

Arteriosclerosis, thrombosis, and vascular biology - 1 May 2016

Belmokhtar Karim, Robert Thomas, Ortillon Jeremy, Braconnier Antoine, Vuiblet Vincent, Boulagnon-Rombi Camille, Diebold Marie Danièle, Pietrement Christine, Schmidt Ann Marie, Rieu Philippe, Touré Fatouma

Abstract excerpt

OBJECTIVE: Cardiovascular disease is the leading cause of death in patients with end-stage renal disease. Serum amyloid A (SAA) is an acute phase protein and a binding partner for the multiligand receptor for advanced glycation end products (RAGE). We investigated the role of the interaction between SAA and RAGE in uremia-related atherogenesis. APPROACH AND RESULTS: We used a mouse model of uremic vasculopathy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aorta
Share to Aortic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myocytes, Smooth Muscle

Share to Nephrectomy

Share to Plaque, Atherosclerotic

Share to Receptor for Advanced Glycation End Products

Share to Serum Amyloid A Protein

Share to Uremia

Source

Identifiers

PMID: 26988587
DOI: 10.1161/ATVBAHA.115.306349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.PMID 26988587Read ↗

Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.Semantic proximity Read ↗

RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and DiseaseSemantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

RAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of ActionsSemantic proximity Read ↗

Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic diseaseSemantic proximity Read ↗

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.Semantic proximity Read ↗

The role of platelet-derived growth factor in uremic vascular calcification.Semantic proximity Read ↗

The role of Platelet-derived growth factor (PDGF) in uremic vascular calcificationSemantic proximity Read ↗

Uremia modulates the phenotype of aortic smooth muscle cells.Semantic proximity Read ↗

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.Semantic proximity Read ↗

Alternative splicing of the murine receptor for advanced glycation end‐products (RAGE) geneSemantic proximity Read ↗

Effects of apolipoprotein M in uremic atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.